Jasper Ridge Partners’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-924
Closed -$6.84K 146
2025
Q2
$6.84K Hold
924
﹤0.01% 147
2025
Q1
$7.95K Hold
924
﹤0.01% 147
2024
Q4
$33K Hold
924
﹤0.01% 143
2024
Q3
$43.7K Hold
924
﹤0.01% 142
2024
Q2
$46.4K Hold
924
﹤0.01% 144
2024
Q1
$103K Hold
924
﹤0.01% 140
2023
Q4
$53.6K Hold
924
﹤0.01% 141
2023
Q3
$29.3K Hold
924
﹤0.01% 143
2023
Q2
$76K Hold
924
﹤0.01% 137
2023
Q1
$94.9K Hold
924
﹤0.01% 143
2022
Q4
$135K Hold
924
0.01% 132
2022
Q3
$156K Hold
924
0.01% 133
2022
Q2
$107K Hold
924
0.01% 137
2022
Q1
$92K Hold
924
﹤0.01% 147
2021
Q4
$144K Hold
924
0.01% 147
2021
Q3
$218K Hold
924
0.01% 138
2021
Q2
$314K Hold
924
0.02% 118
2021
Q1
$374K Sell
924
-121
-12% -$58.7K 0.02% 105
2020
Q4
$695K Buy
1,045
+581
+125% +$323K 0.03% 89
2020
Q3
$216K Buy
+464
New +$234K 0.01% 107

Other funds holding MRSN